Ranibizumab
ophthalmic medicine
Nothing to addWhat this medicine is for
Ranibizumab is a medicine in the « ophthalmic medicine » category. This ophthalmic medicine treats a condition of the eye.
In the case of Ranibizumab, this means: Anti-VEGF for macular degeneration and retinal oedema. How it is used is determined case by case with the professional who prescribes it.
Under which brands it is found
In France, about 5 reimbursable presentations containing Ranibizumab are recorded. It is found under several brand names and as generics.
- Byooviz
- Lucentis
- Ranivisio
- Rimmyrah
- Ximluci
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
We put forward no supplement for Ranibizumab: that would be forcing a need that does not exist. The great majority of medicines call for no particular supplementation, and acknowledging this is part of the way we work. We design a supplement only where the data support it, across five specific classes.
Talk about it in the community
Others are on the same treatment and share their daily life: what they feel, their questions, the little routines they set up. You read lived experience here, not recommendations.
Related molecules
To explore in the « Other areas » family and its neighbours.